Market Overview

More Than Fifty Donators To Help The Fight Against Children's Leukemia Will Ride With Dylan In Pittsburgh

Share:

MVM driver will have his car covered with faces for the fight against children's leukemia

LONG ISLAND, N.Y. (PRWEB) July 19, 2018

Launching the Ride with Dylan (http://www.RideWithDylan.com) program in late June, Dylan Tavella is set to wrap his F4 United States Championship Powered by Honda ride with more than fifty faces of donators. In an effort to give back and help fight against children's leukemia, the Ride With Dylan initiative is a charitable effort and a not-for-profit registered 501 C3 company and allows donators to receive their face on the side of Dylan's racecar.

"We did a soft launch of the program in late June and have just been making people aware of it," explained Tavella. "With the website complete, social media pages done, we started receiving donations and they have continually kept coming. It is great to be able to give back and I can't wait to present a check to Children's Leukemia."

With the next F4 United States Championship Powered by Honda event set for the August 3 – 5 weekend at the Pittsburgh International Race Complex, all people who have donated up until July 23rd will be able to Ride With Dylan as their face will be on the side of the Miller Vinatieri Motorsports machine.

Tavella added, "There is still time to donate and ride with me in two weeks' time."

A direct link to donate to Ride With Dylan can be found here: https://www.ridewithdylan.com/donate/

For more information on Ride With Dylan, please visit http://www.RideWithDylan.com or on any of the social media pages on Facebook, Twitter, Instagram and LinkedIn.

For information on press releases or other media services offered by Race Tech Development, please contact Mike Maurini via e-mail at Info(at)RaceTechDevelopment(dot)com or 317.270.8723. Race Tech Development can also be found on Twitter at @RTDMediaAndMGMT as well as Facebook at their Race Tech Development Fan Page.
-

For the original version on PRWeb visit: https://www.prweb.com/releases/2018/07/prweb15638835.htm

View Comments and Join the Discussion!